Close
Close
Treatment Database
benralizumab
Trade Name Fasenra�
Orphan Indication Hypereosinophilic syndrome
USA Market Approval
USA Designation Date 01-02-2019
Sponsor AstraZeneca Pharmaceuticals LP
P. O. Box 8355, 1800 Concord Pike
Wilmington, Delaware, 19803
More about Idiopathic hypereosinophilic syndrome
Free Newsletter
Related Videos
by Abidemi Uruejoma
423 views